Business Description

Epclusa is suitable for all hepatitis C genotypes. It can be said to be the most effective drug for the treatment of hepatitis C so far. The cure rate is nearly 99%. It is composed of sofosbuvir 400mg + velpatasvir. 100mg composite tablet. The effectiveness and safety of Epclusa have been fully verified in phase III clinical trials, and in the trials, no patients who received treatment experienced serious side effects, making it a perfect hepatitis C treatment medicine.

• Reviews & Ratings
• Write a Review